Ucb SA
XBRU:UCB

Watchlist Manager

Ucb SA

XBRU:UCB

Watchlist

Dividends

Discount Rate

Price: 178 EUR -2.57% Market Closed

Market Cap: 33.8B EUR

Have any thoughts about
Ucb SA?

Write Note

Write Note Create Alert Ask AI

Add Note Why Create Notes?

Capture your thoughts

Note Buy Sell Hold Pass

US	Johnson & Johnson NYSE:JNJ	Pharmaceuticals
US	Estee Lauder Companies Inc NYSE:EL	Consumer products
US	Exxon Mobil Corp NYSE:XOM	Energy
US	Church & Dwight Co Inc NYSE:CHD	Consumer products
US	Pfizer Inc NYSE:PFE	Pharmaceuticals
US	American Express Co NYSE:AXP	Financial Services
US	Nike Inc NYSE:NKE	Textiles, Apparel & Luxury Goods
US	Visa Inc NYSE:V	Technology
CN	Alibaba Group Holding Ltd NYSE:BABA	Retail
US	3M Co NYSE:MMM	Industrial Conglomerates
US	JPMorgan Chase & Co NYSE:JPM	Banking
US	Coca-Cola Co NYSE:KO	Beverages
US	Target Corp NYSE:TGT	Retail
US	Walt Disney Co NYSE:DIS	Media
US	Mueller Industries Inc NYSE:MLI	Machinery
US	PayPal Holdings Inc NASDAQ:PYPL	Technology

Add Price Alert

Price Target:

Last Price: 178 EUR

We'll email you a reminder when the closing price reaches USD.

If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.

Peter Lynch

Track and Analyze Performance

Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.

Continuous Learning and Adaptation

Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.

Boost Decision Confidence

With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.

Why create notes?

Back

Delete Note

Do you really want to delete this note?
This action cannot be undone.

Remove price alert for reaching

Delete

Cancel

UCB Alert

Ucb SA

178

-4.7 (-2.57%)

52 Week Range	67.3 184.5
Price Target

We'll email you a reminder when the closing price reaches EUR.

Save Alert

Choose the stock you wish to monitor with a price alert.

	Johnson & Johnson NYSE:JNJ	US
	Estee Lauder Companies Inc NYSE:EL	US
	Exxon Mobil Corp NYSE:XOM	US
	Church & Dwight Co Inc NYSE:CHD	US
	Pfizer Inc NYSE:PFE	US
	American Express Co NYSE:AXP	US
	Nike Inc NYSE:NKE	US
	Visa Inc NYSE:V	US
	Alibaba Group Holding Ltd NYSE:BABA	CN
	3M Co NYSE:MMM	US
	JPMorgan Chase & Co NYSE:JPM	US
	Coca-Cola Co NYSE:KO	US
	Target Corp NYSE:TGT	US
	Walt Disney Co NYSE:DIS	US
	Mueller Industries Inc NYSE:MLI	US
	PayPal Holdings Inc NASDAQ:PYPL	US

Delete Alert

This alert will be permanently deleted.

Remove note

Delete

Cancel

Ask me anything about

Ucb SA

What unique competitive advantages
does Ucb SA hold over its rivals?

What risks and challenges
does Ucb SA face in the near future?

Is it considered overvalued or undervalued
based on the latest financial data?

Provide an overview of the primary business activities
of Ucb SA.

What unique competitive advantages
does Ucb SA hold over its rivals?

What risks and challenges
does Ucb SA face in the near future?

Is it considered overvalued or undervalued
based on the latest financial data?

Show all valuation multiples
for Ucb SA.

Provide P/S
for Ucb SA.

Provide P/E
for Ucb SA.

Provide P/OCF
for Ucb SA.

Provide P/FCFE
for Ucb SA.

Provide P/B
for Ucb SA.

Provide EV/S
for Ucb SA.

Provide EV/GP
for Ucb SA.

Provide EV/EBITDA
for Ucb SA.

Provide EV/EBIT
for Ucb SA.

Provide EV/OCF
for Ucb SA.

Provide EV/FCFF
for Ucb SA.

Provide EV/IC
for Ucb SA.

Show me price targets
for Ucb SA made by professional analysts.

What are the Revenue projections
for Ucb SA?

How accurate were the past Revenue estimates
for Ucb SA?

What are the Net Income projections
for Ucb SA?

How accurate were the past Net Income estimates
for Ucb SA?

What are the EPS projections
for Ucb SA?

How accurate were the past EPS estimates
for Ucb SA?

What are the EBIT projections
for Ucb SA?

How accurate were the past EBIT estimates
for Ucb SA?

Compare the revenue forecasts
for Ucb SA with those of its competitors based on recent analyst estimates.

Compare the intrinsic valuations
of Ucb SA and its key competitors using the latest financial data.

Compare historical revenue growth rates
of Ucb SA against its competitors.

Analyze the profit margins
(gross, operating, and net) of Ucb SA compared to its peers.

Compare the P/E ratios
of Ucb SA against its peers.

Discuss the investment returns and shareholder value creation
comparing Ucb SA with its peers.

Analyze the financial leverage
of Ucb SA compared to its main competitors.

Show all profitability ratios
for Ucb SA.

Provide ROE
for Ucb SA.

Provide ROA
for Ucb SA.

Provide ROIC
for Ucb SA.

Provide ROCE
for Ucb SA.

Provide Gross Margin
for Ucb SA.

Provide Operating Margin
for Ucb SA.

Provide Net Margin
for Ucb SA.

Provide FCF Margin
for Ucb SA.

Show all solvency ratios
for Ucb SA.

Provide D/E Ratio
for Ucb SA.

Provide D/A Ratio
for Ucb SA.

Provide Interest Coverage Ratio
for Ucb SA.

Provide Altman Z-Score Ratio
for Ucb SA.

Provide Quick Ratio
for Ucb SA.

Provide Current Ratio
for Ucb SA.

Provide Cash Ratio
for Ucb SA.

What is the historical Revenue growth
over the last 5 years for Ucb SA?

What is the historical Net Income growth
over the last 5 years for Ucb SA?

What is the current Free Cash Flow
of Ucb SA?

Discuss the annual earnings per share (EPS)
trend over the past five years for Ucb SA.

EV/EBITDA
Enterprise Value to EBITDA

Current

13.4

Median

13.7

Industry

Higher than median

Higher than industry value

Enterprise Value to EBITDA (EV/EBITDA) ratio is a valuation multiple that compares the value of a company, debt included, to the company’s cash earnings less non-cash expenses. EBITDA can be misleading at times, especially for companies that are highly capital intensive.

EV/EBITDA

Enterprise Value

36.1B EUR

EBITDA

1.2B EUR

All Countries

Forward Multiples

			Market Cap	EV/EBITDA
BE		Ucb SA XBRU:UCB	33.8B EUR	30
JP	N	Nichi-Iko Pharmaceutical Co Ltd TSE:4541	776 550.9T JPY	-5 459 134.4
US		Eli Lilly and Co NYSE:LLY	746.8B USD	48
UK		Dechra Pharmaceuticals PLC LSE:DPH	440.4B GBP	3 846.3
DK		Novo Nordisk A/S CSE:NOVO B	3.3T DKK	24.4
US		Johnson & Johnson NYSE:JNJ	365.6B USD	12
US		Merck & Co Inc NYSE:MRK	249.1B USD	10.4
CH		Roche Holding AG SIX:ROG	208.6B CHF	10.2
CH		Novartis AG SIX:NOVN	181.4B CHF	10
UK		AstraZeneca PLC LSE:AZN	159.6B GBP	169.3
IE	E	Endo International PLC LSE:0Y5F	146B USD	234.4

				EBITDA Growth
BE		Ucb SA XBRU:UCB	Average EV/EBITDA: 439.5 30	112%
JP	N	Nichi-Iko Pharmaceutical Co Ltd TSE:4541	Negative Multiple: -5 459 134.4	N/A
US		Eli Lilly and Co NYSE:LLY	48	194%
UK		Dechra Pharmaceuticals PLC LSE:DPH	3 846.3	151%
DK		Novo Nordisk A/S CSE:NOVO B	24.4	86%
US		Johnson & Johnson NYSE:JNJ	12	13%
US		Merck & Co Inc NYSE:MRK	10.4	339%
CH		Roche Holding AG SIX:ROG	10.2	23%
CH		Novartis AG SIX:NOVN	10	8%
UK		AstraZeneca PLC LSE:AZN	169.3	60%
IE	E	Endo International PLC LSE:0Y5F	234.4	N/A

EV/EBITDA Forward Multiples

Forward EV/EBITDA multiple is a version of the EV/EBITDA ratio that uses forecasted EBITDA for the EV/EBITDA calculation. 1-Year, 2-Years, and 3-Years forwards use EBITDA forecasts for 1, 2, and 3 years ahead, respectively.

1-Year Forward

EV/EBITDA

24.8

2-Years Forward

EV/EBITDA

17.7

3-Years Forward

EV/EBITDA

14.1

Ucb SA
XBRU:UCB

EV/EBITDA
Enterprise Value to EBITDA

EV/EBITDA Forward Multiples

See Also

Company

Help

Tools

Stocks

Ucb SA XBRU:UCB

EV/EBITDA Enterprise Value to EBITDA

EV/EBITDA Forward Multiples

See Also

Company

Help

Tools

Stocks

Ucb SA
XBRU:UCB

EV/EBITDA
Enterprise Value to EBITDA